| Alzheimer’s disease | (AD) |
| Apolipoprotein E | (APOE4) |
| Amyloid-beta | (Aβ) |
| Amyloid precursor protein | (APP) |
| Cerebral amyloid angiopathy | (CAA) |
| Magnetic resonance imaging | (MRI) |
| Reactive oxygen species | (ROS) |
| Divalent metal transporter 1 | (DMT-1) |
| Cytochrome C oxidase assembly homolog | (COX17) |
| Antioxidant protein 1 homolog | (ATOX1) |
| Copper chaperone for SOD | (CCS) |
| Superoxide dismutase1 | (SOD1) |
| Iron responsive element/iron regulatory protein | (IRE/IRP) |
| Transferrin receptor | (TfR) |
| Hereditary haemochromatosis | (HFE) |
| Transferrin saturation | (TSAT) |
| Metallothioneins | (MT) |
| Zn transporters | (ZnT) |
| Zinc-regulated and iron-regulated transporter proteins | (ZIP family) |
| Pantothenate kinase 2 | (PANK2) |
| Phospholipase A2 group VI | (PLA2G6) |
| Fatty acid 2-hydroxylase | (FA2H) |
| ATPase type 13A2 | (ATP13A2) |
| DDB1 and CUL4 associated factor 17 | (DCAF17) |
| Endothelial cells | (BCEC) |
| Blood-Brain-Barrier | (BBB) |
| blood-cerebrospinal fluid-barrier | (BCB) |
| Cerebrospinal fluid | (CSF) |
| Central nervous system | (CNS) |
| Multiple sclerosis | (MS) |
| Parkinson’s disease | (PD) |
| Wilson’s disease | (WD) |
| Loss-of Function | (LoF) |
| Mini Mental State Examination | (MMSE) |
| Mild cognitive impairment | (MCI) |
| Semicarbazide-sensitive amine oxidases | (SSAOs) |
| Vascular dementia | (VaD) |
| Antioxidant capacity | (TAS) |
| Long-term-potentiation | (LTP) |
| Genome-Wide Association Studies | (GWAS) |
| Single nucleotide polymorphisms | (SNPs) |
| Methylenetetrahydrofolate reductase | (MTHFR) |
| Electroencephalographic | (EEG) |